These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22381158)

  • 1. Hypertrophic cardiomyopathy with longevity to 90 years or older.
    Maron BJ; Casey SA; Haas TS; Kitner CL; Garberich RF; Lesser JR
    Am J Cardiol; 2012 May; 109(9):1341-7. PubMed ID: 22381158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Do Patients With Hypertrophic Cardiomyopathy Die from?
    Maron BJ; Rowin EJ; Casey SA; Garberich RF; Maron MS
    Am J Cardiol; 2016 Feb; 117(3):434-5. PubMed ID: 26718233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants for clinical diagnosis of hypertrophic cardiomyopathy.
    Adabag AS; Kuskowski MA; Maron BJ
    Am J Cardiol; 2006 Dec; 98(11):1507-11. PubMed ID: 17126660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors.
    Spirito P; Autore C; Formisano F; Assenza GE; Biagini E; Haas TS; Bongioanni S; Semsarian C; Devoto E; Musumeci B; Lai F; Yeates L; Conte MR; Rapezzi C; Boni L; Maron BJ
    Am J Cardiol; 2014 May; 113(9):1550-5. PubMed ID: 24630786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.
    Cecchi F; Olivotto I; Montereggi A; Santoro G; Dolara A; Maron BJ
    J Am Coll Cardiol; 1995 Nov; 26(6):1529-36. PubMed ID: 7594081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
    Efthimiadis GK; Parcharidou DG; Giannakoulas G; Pagourelias ED; Charalampidis P; Savvopoulos G; Ziakas A; Karvounis H; Styliadis IH; Parcharidis GE
    Am J Cardiol; 2009 Sep; 104(5):695-9. PubMed ID: 19699347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.
    Bos JM; Maron BJ; Ackerman MJ; Haas TS; Sorajja P; Nishimura RA; Gersh BJ; Ommen SR
    Am J Cardiol; 2010 Nov; 106(10):1481-6. PubMed ID: 21059440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Fananapazir L
    Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
    Spirito P; Autore C; Rapezzi C; Bernabò P; Badagliacca R; Maron MS; Bongioanni S; Coccolo F; Estes NA; Barillà CS; Biagini E; Quarta G; Conte MR; Bruzzi P; Maron BJ
    Circulation; 2009 Apr; 119(13):1703-10. PubMed ID: 19307481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic features of exertional versus nonexertional sudden death in patients with hypertrophic cardiomyopathy.
    Tavora F; Cresswell N; Li L; Ripple M; Fowler D; Burke A
    Am J Cardiol; 2010 Feb; 105(4):532-7. PubMed ID: 20152250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.